Arrowhead Pharmaceuticals, Inc. ARWR
NASDAQ · United States · Health Technology
$64.79-0.66 (-1.01%)
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q3 2026 | 2026-08-04 | -1.36 | -1.28 | -6.5% | $75.25M | +70.4% | +1.0%$86.01→$86.91 |
| Q2 2026 | 2026-05-07 | -0.93 | -1.11 | +16.2% | — | — | -8.2%$79.14→$72.69 |
| Q1 2026 | 2026-02-05 | 0.22 | -0.37 | +159.5% | — | — | -5.2%$68.06→$64.52 |
| Q4 2025 | 2025-11-25 | -0.18 | -0.16 | -12.5% | — | — | +30.4%$44.26→$57.71 |
| Q3 2025 | 2025-08-07 | -1.26 | -1.10 | -14.5% | — | — | — |
| Q2 2025 | 2025-05-12 | 2.75 | -0.46 | +697.8% | — | — | — |
| Q1 2025 | 2025-02-10 | -1.39 | -0.72 | -93.1% | — | — | — |
| Q4 2024 | 2024-11-26 | -1.37 | -0.92 | -48.9% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.